Kim Kelderman - Sep 8, 2025 Form 4 Insider Report for CONMED Corp (CNMD)

Role
Director
Signature
/s/ Thomas Fistek for Kim Kelderman by Power of Attorney
Stock symbol
CNMD
Transactions as of
Sep 8, 2025
Transactions value $
$0
Form type
4
Date filed
9/9/2025, 04:13 PM
Previous filing
Aug 19, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kelderman Kim Director C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO /s/ Thomas Fistek for Kim Kelderman by Power of Attorney 2025-09-09 0001739054

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD RSUs (Restricted Stock Units) Award $0 +500 $0.00 500 Sep 8, 2025 Common Stock 500 $0.00 Direct F1, F2
transaction CNMD Options To Purchase Common Stock Award $0 +6.23K $0.00 6.23K Sep 8, 2025 Common Stock 6.23K $53.83 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.
F2 The stock options were granted under the 2025 Long-Term Incentive Plan of CONMED Corporation (the "Company) and generally vest 100% 1 year from the grant date.